Related Experiment Video
Updated: Apr 16, 2026

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
microRNA-107 functions as a candidate tumor suppressor gene in renal clear cell carcinoma involving multiple genes
Nan Song1, Xin Ma1, Hongzhao Li1
1Department of Urology, Chinese PLA General Hospital, Beijing, China.
Background:
MicroRNAs (miRNAs) are small RNAs with oncogenic and tumor-suppressing functions in cancer. miRNAs not only regulate various target genes but also participate in vital signaling pathways.
Methods And Results:
The tumor-suppressing function of miRNA-107 (miR-107) was confirmed in clear cell renal cell carcinoma in 52 paired clinical specimens and renal cell carcinoma cell lines. Significant correlations were noted between clinical features and miR-107 expression level. Lentiviral vector and biosynthesis mimics were used to overexpress pre-miR-107 or mimicked miR-107 to investigate further the tumorigenesis of miR-107 in vivo and in vitro. Cell proliferation and invasiveness were inhibited in the 786-O cell line after miR-107 was delivered. High miR-107 level expression can apparently induce cell cycle arrest at the G2/M phase and retard tumor growth in nude mice. In addition, eukaryotic translation initiation factor 5 was found to be a direct target of miR-107 and exhibited an inverse relationship with miR-107. It was seen that p53 and VHL genes, which are implicated in renal tumors, were associated with miR-107.
Conclusion:
In summary, our results showed that miR-107 can inhibit cell proliferation and invasiveness of renal cell carcinoma. Furthermore, this study may provide a potential therapeutic regimen for clear cell renal cell carcinoma treatment.
Insights
MicroRNA-107 (miR-107) suppresses clear cell renal cell carcinoma by inhibiting cell proliferation and invasion. This finding offers a potential therapeutic strategy for renal cell carcinoma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
- miRNAs play dual roles as oncogenes or tumor suppressors in cancer.
- Dysregulation of miRNAs is implicated in tumorigenesis and cancer progression.
Purpose of the Study:
- To investigate the role of microRNA-107 (miR-107) in clear cell renal cell carcinoma (ccRCC).
- To explore the potential of miR-107 as a therapeutic agent for ccRCC.
Main Methods:
- Analysis of miR-107 expression in 52 paired clinical ccRCC specimens and cell lines.
- Overexpression of miR-107 using lentiviral vectors and biosynthesis mimics in vitro and in vivo.
- Assessment of cell proliferation, invasion, cell cycle, and tumor growth.
- Identification of direct miR-107 targets using molecular assays.
Main Results:
- miR-107 exhibited tumor-suppressing functions in ccRCC.
- miR-107 overexpression inhibited proliferation and invasiveness of ccRCC cells (786-O).
- High miR-107 levels induced G2/M phase cell cycle arrest and retarded tumor growth in vivo.
- Eukaryotic translation initiation factor 5 was identified as a direct target of miR-107.
- miR-107 expression was associated with p53 and VHL genes in ccRCC.
Conclusions:
- miR-107 acts as a tumor suppressor in ccRCC by inhibiting cell proliferation and invasiveness.
- miR-107 holds potential as a therapeutic target for ccRCC treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

